Empresa MiMedx Group Inc Nasdaq
Acciones
US6024961012
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Hospital
58,2
%
| - | - | 187 | 58,2 % | - |
Private Office
29,8
%
| - | - | 96 | 29,8 % | - |
Other
12,0
%
| - | - | 39 | 12,0 % | - |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 268 | 100,0 % | 321 | 100,0 % | +20,03 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Joe Capper
CEO | Chief Executive Officer | 60 | 27/01/23 |
Douglas Rice
DFI | Director of Finance/CFO | 58 | 05/07/23 |
John R. Harper
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/21 |
Mark P. Graves
CMP | Compliance Officer | 59 | 01/07/18 |
Ricci Whitlow
COO | Chief Operating Officer | 55 | 03/01/23 |
William Hulse
ADM | Chief Administrative Officer | 50 | 02/12/19 |
David H. Mason
CTO | Chief Tech/Sci/R&D Officer | 77 | 19/06/14 |
K. Newton
BRD | Director/Board Member | 61 | 19/06/19 |
Eric Smith
SAM | Sales & Marketing | - | 01/01/21 |
Kim Moller
SAM | Sales & Marketing | - | 01/08/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
William Hawkins
BRD | Director/Board Member | 70 | 02/07/20 |
Phyllis Gardner
BRD | Director/Board Member | 73 | 08/03/21 |
K. Newton
BRD | Director/Board Member | 61 | 19/06/19 |
M. Wilsey
CHM | Chairman | 71 | 19/06/19 |
James Bierman
BRD | Director/Board Member | 71 | 19/06/19 |
Martin Sutter
BRD | Director/Board Member | 68 | 02/07/20 |
Joe Capper
CEO | Chief Executive Officer | 60 | 27/01/23 |
Michael Giuliani
BRD | Director/Board Member | 69 | 20/11/20 |
Cato Laurencin
BRD | Director/Board Member | 65 | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 147 603 955 | 144 292 915 ( 97,76 %) | 0 | 97,76 % |
Información de la empresa
Sector
Ventas por actividad
Varia. 1 de ene. | Capi. | |
---|---|---|
-19,63 % | 131 M | |
-8,45 % | 67 M | |
+6,91 % | 61,28 M | |
+8,27 % | 58,63 M | |
-1,80 % | 51,45 M |